WW INTERNATIONAL INC (WW)
NASDAQHealth CarePersonal Products & ServicesSnapshot 2026-11-05
$12.84+5.85%
Close 2026-11-05 · 1-day change
NASDAQHealth CarePersonal Products & ServicesSnapshot 2026-11-05
QuarterlyIQ Insights · WW
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -81.5% |
| Our one-year growth estimate | diamond | -3.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 78.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and its industry peers have been missing lately. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 3 industry peers
WW — CEO transition
Dated 2026-09-21
CEO — Stephen J. Bye: The filing announces the appointment of a new external CEO and the dissolution of the interim executive structure, which is a significant leadership change but not a loss of a sitting permanent executive.
Why it matters: Stephen J. Bye became CEO in September. His first earnings update can show whether leadership keeps the current growth and debt plans.
Watch forOn Nov. 5, Bye backs the 2026 revenue and EBITDA ranges and names steps to grow Clinical and Core+.
Also watch forOn Nov. 5, Bye cuts the 2026 ranges or states that the Clinical or Core+ plans have changed.
Why it matters: WW paid down $41.4 million of loan principal in Q2 and held $101.5 million in cash. Less cash generation could limit its room to act.
Worry ifWW reports negative operating cash flow for Q3 or cash below $77 million, down more than $24.3 million from Q2.
Less concerning ifWW reports positive Q3 operating cash flow and cash at or above $101.5 million.
Why it matters: WW held adjusted gross margin at 73.6% in both Q1 and Q2. A drop would weaken evidence that cost cuts are holding.
Worry ifWW reports Q3 adjusted gross margin below 73.0%.
Less concerning ifWW reports Q3 adjusted gross margin at or above 73.6%.
Why it matters: Clinical subscribers grew 55.7% in Q2, but stayed flat from Q1. More growth would support the Clinical expansion story.
Supportive ifOn the Nov. 5 earnings call, WW reports Q3 Clinical subscribers above 197,000 and up year over year.
Worry ifWW reports Q3 Clinical subscribers below 197,000 or down year over year.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$326 on $10,000 · ±3.3% | How much price usually moves either way. |
| Bad day | $974 loss on $10,000 · 9.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,351 loss on $10,000 · 73.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Core+ has grown for three quarters in a row. A fourth quarter of growth would support a steadier Behavioral business.
Supportive ifWW reports more than 541,000 Q3 Core+ subscribers and grows again from the prior quarter.
Worry ifWW reports Q3 Core+ subscribers at or below 541,000, ending the run of sequential growth.